The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 “boost versus no boost” trial

Autor: Poortmans, P.M., Collette, L., Bartelink, H., Struikmans, H., Van den Bogaert, W.F., Fourquet, A., Jager, J.J., Hoogenraad, W., Müller, R.-P., Dubois, J.-B., Bolla, M., Van Der Hulst, M., Wárlám-Rodenhuis, C.C., Pierart, M., Horiot, J.-C.

Publikováno v: In Cancer / Radiothérapie 2008 12(6):565-570

Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance: Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group

Autor: Bosset, J.F., Calais, G., Daban, A., Berger, C., Radosevic-Jelic, L., Maingon, P., Bardet, E., Pierart, M., Briffaux, A.

Publikováno v: In European Journal of Cancer January 2004 40(2):219-224

The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts

Autor: Kouloulias, V.E., Poortmans, P.M., Bernier, J., Horiot, J.-C., Johansson, K.-A., Davis, B., Godson, F., Garavaglia, G., Pierart, M., van der Schueren, E.

Publikováno v: In European Journal of Cancer 2003 39(4):430-437

Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)

Autor: Matzinger, O., Heimsoth, I., Poortmans, P., Collette, L., Struikmans, H., Bogaert, W. van den, Fourquet, A., Bartelink, H., Ataman, F., Gulyban, A., Pierart, M., Tienhoven, G. van, EORTC Radiation Oncology Grp, Breast Canc Grp

Publikováno v: Acta oncologica (Stockholm, Sweden), 49(1), 24-34. Informa Healthcare
Acta Oncologica
Acta Oncologica, Taylor & Francis, 2010, 49 (1), pp.24-34. ⟨10.3109/02841860903352959⟩
Acta Oncologica, Taylor & Francis, 2010, 49 (1), pp.24-34. 〈10.3109/02841860903352959〉
Acta Oncologica, 49(1), 24-34

National audience; INTRODUCTION: The EORTC 22922/10925 trial investigated the potential survival benefit and toxicity of elective irradiation of the internal mammary and medial supraclavicular (IM-MS) nodes Accrual completed in January 2004 and first

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e853d074d6048b43b24789bbf421b9a
https://pure.amc.nl/en/publications/toxicity-at-three-years-with-and-without-irradiation-of-the-internal-mammary-and-medial-supraclavicular-lymph-node-chain-in-stage-i-to-iii-breast-cancer-eortc-trial-2292210925(a92a3f38-f413-4ca6-a213-6e1d7882a798).html

Postoperative radiotherapy with or without elective irradiation of paraortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group

Autor: Bosset, Jf, Horiot, Jc, Cionini, Luca, Bartelink, H, Caspers, R, Untereiner, M, Ciambellotti, E, Pierart, M, VAN GLABBEKE, M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3728::3fa9eb48148aebe94e08100c8fde89c2
http://hdl.handle.net/11568/177916